160 related articles for article (PubMed ID: 35623354)
1. Lack of Cas13a inhibition by anti-CRISPR proteins from Leptotrichia prophages.
Johnson MC; Hille LT; Kleinstiver BP; Meeske AJ; Bondy-Denomy J
Mol Cell; 2022 Jun; 82(11):2161-2166.e3. PubMed ID: 35623354
[TBL] [Abstract][Full Text] [Related]
2. tRNA anticodon cleavage by target-activated CRISPR-Cas13a effector.
Jain I; Kolesnik M; Kuznedelov K; Minakhin L; Morozova N; Shiriaeva A; Kirillov A; Medvedeva S; Livenskyi A; Kazieva L; Makarova KS; Koonin EV; Borukhov S; Severinov K; Semenova E
Sci Adv; 2024 Apr; 10(17):eadl0164. PubMed ID: 38657076
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells.
Lin P; Qin S; Pu Q; Wang Z; Wu Q; Gao P; Schettler J; Guo K; Li R; Li G; Huang C; Wei Y; Gao GF; Jiang J; Wu M
Mol Cell; 2020 Jun; 78(5):850-861.e5. PubMed ID: 32348779
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.
Wang B; Zhang T; Yin J; Yu Y; Xu W; Ding J; Patel DJ; Yang H
Mol Cell; 2021 Mar; 81(5):1100-1115.e5. PubMed ID: 33472057
[TBL] [Abstract][Full Text] [Related]
5. RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes.
East-Seletsky A; O'Connell MR; Burstein D; Knott GJ; Doudna JA
Mol Cell; 2017 May; 66(3):373-383.e3. PubMed ID: 28475872
[TBL] [Abstract][Full Text] [Related]
6. A phage-encoded anti-CRISPR enables complete evasion of type VI-A CRISPR-Cas immunity.
Meeske AJ; Jia N; Cassel AK; Kozlova A; Liao J; Wiedmann M; Patel DJ; Marraffini LA
Science; 2020 Jul; 369(6499):54-59. PubMed ID: 32467331
[TBL] [Abstract][Full Text] [Related]
7. AcaFinder: Genome Mining for Anti-CRISPR-Associated Genes.
Yang B; Zheng J; Yin Y
mSystems; 2022 Dec; 7(6):e0081722. PubMed ID: 36413017
[TBL] [Abstract][Full Text] [Related]
8. RNA targeting with CRISPR-Cas13.
Abudayyeh OO; Gootenberg JS; Essletzbichler P; Han S; Joung J; Belanto JJ; Verdine V; Cox DBT; Kellner MJ; Regev A; Lander ES; Voytas DF; Ting AY; Zhang F
Nature; 2017 Oct; 550(7675):280-284. PubMed ID: 28976959
[TBL] [Abstract][Full Text] [Related]
9. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
Yang H; Patel DJ
Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
[TBL] [Abstract][Full Text] [Related]
10. Bacteriophages suppress CRISPR-Cas immunity using RNA-based anti-CRISPRs.
Camara-Wilpert S; Mayo-Muñoz D; Russel J; Fagerlund RD; Madsen JS; Fineran PC; Sørensen SJ; Pinilla-Redondo R
Nature; 2023 Nov; 623(7987):601-607. PubMed ID: 37853129
[TBL] [Abstract][Full Text] [Related]
11. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
[TBL] [Abstract][Full Text] [Related]
12. Composition and Diversity of CRISPR-Cas13a Systems in the Genus
Watanabe S; Cui B; Kiga K; Aiba Y; Tan XE; Sato'o Y; Kawauchi M; Boonsiri T; Thitiananpakorn K; Taki Y; Li FY; Azam AH; Nakada Y; Sasahara T; Cui L
Front Microbiol; 2019; 10():2838. PubMed ID: 31921024
[TBL] [Abstract][Full Text] [Related]
13. Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28.
Smargon AA; Cox DBT; Pyzocha NK; Zheng K; Slaymaker IM; Gootenberg JS; Abudayyeh OA; Essletzbichler P; Shmakov S; Makarova KS; Koonin EV; Zhang F
Mol Cell; 2017 Feb; 65(4):618-630.e7. PubMed ID: 28065598
[TBL] [Abstract][Full Text] [Related]
14. RNA virus interference via CRISPR/Cas13a system in plants.
Aman R; Ali Z; Butt H; Mahas A; Aljedaani F; Khan MZ; Ding S; Mahfouz M
Genome Biol; 2018 Jan; 19(1):1. PubMed ID: 29301551
[TBL] [Abstract][Full Text] [Related]
15. The Cas6e ribonuclease is not required for interference and adaptation by the E. coli type I-E CRISPR-Cas system.
Semenova E; Kuznedelov K; Datsenko KA; Boudry PM; Savitskaya EE; Medvedeva S; Beloglazova N; Logacheva M; Yakunin AF; Severinov K
Nucleic Acids Res; 2015 Jul; 43(12):6049-61. PubMed ID: 26013814
[TBL] [Abstract][Full Text] [Related]
16. Type II anti-CRISPR proteins as a new tool for synthetic biology.
Zhang Y; Marchisio MA
RNA Biol; 2021 Aug; 18(8):1085-1098. PubMed ID: 32991234
[TBL] [Abstract][Full Text] [Related]
17. The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a.
Liu L; Li X; Ma J; Li Z; You L; Wang J; Wang M; Zhang X; Wang Y
Cell; 2017 Aug; 170(4):714-726.e10. PubMed ID: 28757251
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of CRISPR-Cas9 with Bacteriophage Proteins.
Rauch BJ; Silvis MR; Hultquist JF; Waters CS; McGregor MJ; Krogan NJ; Bondy-Denomy J
Cell; 2017 Jan; 168(1-2):150-158.e10. PubMed ID: 28041849
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas Controls Cryptic Prophages.
Song S; Semenova E; Severinov K; Fernández-García L; Benedik MJ; Maeda T; Wood TK
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555835
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.
O'Connell MR
J Mol Biol; 2019 Jan; 431(1):66-87. PubMed ID: 29940185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
